The interaction of αvβ3 integrin with osteopontin activates the FAK signaling pathway to suppress apoptosis, resulting in epidermal growth factor-tyrosine kinase inhibitor (EGFR-TKI) resistance in non-small cell lung cancer with EGFR-mutation [10]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.